Literature DB >> 3352063

A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization.

R M Morse1, M I Resnick.   

Abstract

Despite intense investigation, the relationship of urinary proteins to urinary stone matrix formation remains poorly understood. In an attempt to gain more information regarding this interaction, the binding of urinary proteins to calcium oxalate crystals formed in urine in vitro was studied. 0.1 M calcium chloride and 0.1 M sodium oxalate were added to an aliquot of urine collected from five non-infected, non-stone forming males. The resulting calcium oxalate crystals were centrifuged and the pellet demineralized with 5% EDTA. Gel filtration chromatography was used to isolate the protein fraction from the urine samples before and after crystallization of calcium oxalate. The proteins recovered from the crystals and urine were separated by two-dimensional polyacrylamide gel electrophoresis. Many, but not all of the urinary proteins were bound by the crystals. Albumin, seen to the most abundant urinary protein, was absent or markedly diminished in all instances, and the second most abundant urinary protein, PC-30, became the predominant protein component of the crystals. An unidentified protein with approximate molecular weight of 22,000 daltons and isoelectric point of 6.4 was highly concentrated by the crystals even when undetected in the urine. The study suggests that the binding of urinary proteins to calcium oxalate crystals formed in urine in vitro is not a random event but rather a selective phenomenon.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3352063     DOI: 10.1016/s0022-5347(17)42665-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

1.  Urinary crystal surface binding substances on calcium oxalate crystals.

Authors:  T Koide; T Yoshioka; S Yamaguchi; S Hosokawa; M Utsunomiya; T Sonoda
Journal:  Urol Res       Date:  1990

2.  The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals.

Authors:  Rosemary Lyons Ryall; Phulwinder K Grover; Lauren A Thurgood; Magali C Chauvet; David E Fleming; Wilhelm van Bronswijk
Journal:  Urol Res       Date:  2007-02-03

Review 3.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

4.  Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine.

Authors:  F Atmani; F J Opalko; S R Khan
Journal:  Urol Res       Date:  1996

Review 5.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

Review 6.  The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin.

Authors:  K Suzuki; M Moriyama; C Nakajima; K Kawamura; K Miyazawa; R Tsugawa; N Kikuchi; K Nagata
Journal:  Urol Res       Date:  1994

Review 8.  Oxalate binding proteins in calcium oxalate nephrolithiasis.

Authors:  Ramasamy Selvam; Periandavan Kalaiselvi
Journal:  Urol Res       Date:  2003-07-11

9.  Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.

Authors:  S Sørensen; S J Justesen; A H Johnsen
Journal:  Urol Res       Date:  1995

Review 10.  Kidney stones.

Authors:  Saeed R Khan; Margaret S Pearle; William G Robertson; Giovanni Gambaro; Benjamin K Canales; Steeve Doizi; Olivier Traxer; Hans-Göran Tiselius
Journal:  Nat Rev Dis Primers       Date:  2016-02-25       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.